Manufacturing: Pharmaceutical and biopharmaceutical manufacturing, scale-up, and related processes - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Manufacturing
Equipment and processing in pharma, biopharma, specialty & generic drug manufacturing. Aseptic processing, cytotoxic manufacturing, small & large molecules.

Pharma Investments Reflect Key Industry Trends

August 2, 2014

Pharmaceutical Technology

Shrinking facility size, growth of biologics, and emerging market demand influence pharma investments.

Comparing Manufacturing Process Options

August 2, 2014

Pharmaceutical Technology

A techno-economic profiling method supports pharmaceutical process development by helping identify the best manufacturing approach.

Industry Takes Steps to Prevent Counterfeit Drugs

August 2, 2014

Pharmaceutical Technology

The fight against counterfeit drugs is an international effort, as exemplified by the ?Fight the Fakes? campaign.

Implementing Supply-Chain Security

August 2, 2014

Pharmaceutical Technology

The US federal Drug Quality and Security Act (DQSA) and more specifically the Drug Supply Chain Security Act (DSCSA), referring to Title II of the law, requires phase-in of requirements to prevent counterfeiting. An expert discusses how companies should be preparing to meet the requirements of the DSCSA.

Trends in Single-Use Biomanufacturing

August 1, 2014

Pharmaceutical Technology Europe

Single-use technologies have gained broad acceptance in biomanufacturing within the past few years, supporting flexible and cost-effective clinical production.

Contractors Invest in Capacity and Capabilities

August 1, 2014
Pharmaceutical Technology

Contract research, development, and manufacturing organizations invested in new facilities and technologies in 2014 for analytical testing, as well as small- and large-molecule drug development.

Single-Use and Continuous Processing Technologies Change Facility Design

August 1, 2014

Pharmaceutical Technology Europe

Single use has introduced a level of flexibility into facilities that was either unheard of or very expensive in a stainless-steel environment.

Single-Use Systems: Enabling the Future of Biologics Manufacturing

August 1, 2014

Pharmaceutical Technology Europe

Single-use technologies, which started off as a tool for small-volume solution storage and transport has now become the central, enabling technology around which manufacturing processes and facilities are being designed.

Trends in Tablet Tooling

August 1, 2014

Pharmaceutical Technology Europe

Tool coatings are now seen as an acceptable means of solving production problems, such as sticking and corrosion, resulting in increased product yield.

ADVERTISEMENT

LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
FDASIA was signed into law two years ago. Where has the most progress been made in implementation?
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
Reducing drug shortages
70%
Breakthrough designations
4%
Protecting the supply chain
17%
Expedited reviews of drug submissions
2%
More stakeholder involvement
7%
View Results
Eric Langerr Outsourcing Outlook Eric LangerRelationship-building at Top of Mind for Clients
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerRisk Reduction Top Driver for Biopharmaceutical Raw Material Development
Jill Wechsler Regulatory Watch Jill Wechsler Changes and Challenges for Generic Drugs
Faiz Kermaini Industry Insider Faiz KermainiNo Signs of a Slowdown in Mergers
Click here